{"schema_version":"secwatch.filing_event.v1","accession":"0001655759-24-000091","form_type":"8-K","ticker":"ARVN","cik":"0001655759","company_name":"ARVINAS, INC.","filed_at":"2024-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.450723+00:00","generated_at":"2026-06-01T04:07:18.164523+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Arvinas appoints Ian Taylor as President of R&D, Angela Cacace as CSO","bullets":["Ian Taylor, Ph.D., formerly CSO, becomes President of R&D effective June 15, 2024.","Angela Cacace, Ph.D., formerly SVP Neuroscience and Platform Biology, appointed CSO.","Cacace joined Arvinas in 2018 and will drive early research pipeline.","Taylor will also chair the company's scientific advisory board."],"urls":{"canonical":"https://secwatch.observer/filing/0001655759-24-000091","json":"https://secwatch.observer/filing/0001655759-24-000091.json","markdown":"https://secwatch.observer/filing/0001655759-24-000091.md","text":"https://secwatch.observer/filing/0001655759-24-000091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/arvn-20240615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:07:18.164523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b68264034a","claim":"Angela Cacace was appointed as Chief Scientific Officer at ARVINAS, INC..","evidence_excerpt":"and the appointment of Angela Cacace, Ph.D. as the Company’s chief scientific officer (“CSO”), a role previously held by Dr. Taylor.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Scientific Officer"}],"fact_type":"executive_change"},{"claim_id":"ef76a3e008","claim":"Ian Taylor was appointed as President of Research and Development at ARVINAS, INC..","evidence_excerpt":"On June 17, 2024, Arvinas, Inc., a Delaware corporation (the “Company”), announced the appointment of Ian Taylor, Ph.D. as the Company’s president of research and development (“R&D”), a role previously held by John Houston, Ph.D.,","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1655759/000165575924000091/0001655759-24-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President of Research and Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}